311 related articles for article (PubMed ID: 23603201)
1. Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.
Kosaraju J; Gali CC; Khatwal RB; Dubala A; Chinni S; Holsinger RM; Madhunapantula VS; Muthureddy Nataraj SK; Basavan D
Neuropharmacology; 2013 Sep; 72():291-300. PubMed ID: 23603201
[TBL] [Abstract][Full Text] [Related]
2. Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease.
Kosaraju J; Murthy V; Khatwal RB; Dubala A; Chinni S; Muthureddy Nataraj SK; Basavan D
J Pharm Pharmacol; 2013 Dec; 65(12):1773-84. PubMed ID: 24117480
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
Kosaraju J; Madhunapantula SV; Chinni S; Khatwal RB; Dubala A; Muthureddy Nataraj SK; Basavan D
Behav Brain Res; 2014 Jul; 267():55-65. PubMed ID: 24667360
[TBL] [Abstract][Full Text] [Related]
4. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Kosaraju J; Holsinger RMD; Guo L; Tam KY
Mol Neurobiol; 2017 Oct; 54(8):6074-6084. PubMed ID: 27699599
[TBL] [Abstract][Full Text] [Related]
5. DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling.
Chen S; Zhou M; Sun J; Guo A; Fernando RL; Chen Y; Peng P; Zhao G; Deng Y
Neuropharmacology; 2019 Oct; 157():107668. PubMed ID: 31199957
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
7. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
Akarte AS; Srinivasan BP; Gandhi S
J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
9. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Gallwitz B
IDrugs; 2008 Dec; 11(12):906-17. PubMed ID: 19051153
[TBL] [Abstract][Full Text] [Related]
10. (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.
Li L; Zhang ZF; Holscher C; Gao C; Jiang YH; Liu YZ
Eur J Pharmacol; 2012 Jan; 674(2-3):280-6. PubMed ID: 22115895
[TBL] [Abstract][Full Text] [Related]
11. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.
Gao C; Liu Y; Jiang Y; Ding J; Li L
Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968
[TBL] [Abstract][Full Text] [Related]
12. Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures.
Kim DH; Huh JW; Jang M; Suh JH; Kim TW; Park JS; Yoon SY
Neurobiol Dis; 2012 Apr; 46(1):52-8. PubMed ID: 22245388
[TBL] [Abstract][Full Text] [Related]
13. Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease.
Rahman SO; Kaundal M; Salman M; Shrivastava A; Parvez S; Panda BP; Akhter M; Akhtar M; Najmi AK
Eur J Pharmacol; 2020 Dec; 889():173522. PubMed ID: 32866503
[TBL] [Abstract][Full Text] [Related]
14. Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor.
Boulton DW
Clin Pharmacokinet; 2017 Jan; 56(1):11-24. PubMed ID: 27282159
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses.
Chu S; Gu J; Feng L; Liu J; Zhang M; Jia X; Liu M; Yao D
Int Immunopharmacol; 2014 Apr; 19(2):317-26. PubMed ID: 24503167
[TBL] [Abstract][Full Text] [Related]
16. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
17. The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.
Li C; Liu W; Li X; Zhang Z; Qi H; Liu S; Yan N; Xing Y; Hölscher C; Wang Z
Brain Behav; 2020 Mar; 10(3):e01505. PubMed ID: 31960630
[TBL] [Abstract][Full Text] [Related]
18. Saxagliptin: a novel antiparkinsonian approach.
Nassar NN; Al-Shorbagy MY; Arab HH; Abdallah DM
Neuropharmacology; 2015 Feb; 89():308-17. PubMed ID: 25446674
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
Siddiqui N; Ali J; Parvez S; Najmi AK; Akhtar M
Neurochem Res; 2023 Sep; 48(9):2714-2730. PubMed ID: 37079222
[TBL] [Abstract][Full Text] [Related]
20. Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease.
Li J; Wang YJ; Zhang M; Fang CQ; Zhou HD
Life Sci; 2011 Jul; 89(3-4):86-92. PubMed ID: 21620868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
